SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-025725
Filing Date
2024-07-01
Accepted
2024-07-01 08:00:57
Documents
14
Period of Report
2024-07-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 68013
  Complete submission text file 0001493152-24-025725.txt   291675

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sava-20240701.xsd EX-101.SCH 3777
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sava-20240701_def.xml EX-101.DEF 26614
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sava-20240701_lab.xml EX-101.LAB 36650
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sava-20240701_pre.xml EX-101.PRE 25238
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5687
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41905 | Film No.: 241088216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)